Decree No. 473 / 2008 Coll.
Ordonnance on the epidemiological vigilance system for selected infections
Valid
Order
Effective from 01.01.2009
Zobrazeno prvních 200 z celkem 1428 ustanovení tohoto předpisu.
Zobrazit celý předpis →
Pro stažení celého znění použijte tlačítko Stáhnout výše.
473
DECLARATION
of 17 December 2008
on the epidemiological vigilance system for selected infections
The Ministry of Health provides pursuant to § 108 (1) of Act No. 258 / 2000 Coll., on the Protection of Public Health and on the Amendment of Certain Related Acts, as amended by Act No. 274 / 2003 Coll., Act No. 320 / 2002 Coll., Act No. 274 / 2003 Coll., Act No. 392 / 2005 Coll., Act No. 222 / 2006 Coll. and Act No. 110 / 2007 Coll., hereinafter "the Act ', for the implementation of § 75a (1) and (4) of the Act:
This Decree regulates the extent of infections for which an epidemiological vigilance system (surveillance) is in place and provides for:
(a) the extent of the data collected on infections, the manner and time limits of their reporting;
(b) laboratory diagnosis, epidemiological investigation and identification of the type and manner of implementation of anti-epidemic measures for infectious diseases;
(c) the essential characteristics, the clinical definition and classification of infectious diseases.
The infections included in the epidemiological vigilance system are listed in Annex 1 to this Decree.
(1) The scope of the data and the procedure provided for in Article 1 (a) to (c) shall be regulated by the occurrence of:
(a) diphtheria Annex No 2 to this Decree;
(b) gouge cough Annex 3 to this Decree,
(c) measles Annex 4 to this Decree;
(d) influenza and acute respiratory infections Annex 5 to this Decree;
(e) invasive meningococcal disease Annex 6 to this Decree;
(f) invasive diseases caused by Haemophilus influenzae type b and non- b Annex No 7 to this Decree;
(g) diseases caused by the Human Immunodeficiency Virus (HIV / AIDS) Annex 8 thereto,
(h) tuberculosis Annex 9 to this Decree;
(i) Legionelosis Annex 10 to this Decree;
(j) portable polio (poliomyelitis) Annex 11 to this Decree;
(k) tetanus Annex 12 to this Decree;
(l) rubella and congenital rubella syndrome (KZS) Annex 13 to this Decree;
(m) mumps Annex 14 to this decree.
(2) The scope of the data and the procedure provided for in Articles 1 (a) to (c) are further adjusted where:
(a) West Nile fever Annex 15 to this Decree;
(b) by enterohaemorrhagic Escherichia coli (EEC) Annex No 16 to this Decree;
(c) Viral hepatitis A Annex 17 to this Decree;
(d) Viral hepatitis B Annex 18 to this Decree;
(e) Viral hepatitis C Annex 19 to this Decree;
(f) Chlamydia trachomatis Annex No 20 to this Decree,
(g) invasive pneumococcal diseases Annex 21 to this Decree;
(h) campylobacteriosis Annex No 22 to this Decree;
(i) Lyme disease Annex No 23 to this Decree;
(j) belt herpes Annex 24 to this Decree;
(k) rotavirus infections Annex 25 to this Decree;
(l) salmonella Annex No 26 to this Decree,
(m) obtained or congenital syphilis Annex No 27 to this Decree;
(n) tick encephalitis Annex No 28 to this Decree;
(o) varicella Annex 29 to this Decree;
(p) Viral hepatitis E Annex 30 to this Decree.
The person providing care (1) shall report to the public health authority the data collected on infections under Section 2. When suspected and detected each individual case of infectious disease as referred to in Section 3, it shall be carried out to the extent specified in Annexes 2 to 30 to this Decree. The report shall be submitted within the time limits and in a manner specified by other legislation (m2).
This Decree shall take effect on 1 January 2009.
Minister:
Dr. Julinek, MBA v. r.
Příloha č. 1
Annex No 1 to Decree No 473 / 2008 Coll.
Infections included in the epidemiological vigilance system
1.
1.1. Diseases that can be prevented by vaccination:
Diphtheria
Infection causing Haemophilus influenza type b and non b
Influenza
Combustion plants
Mumps
Vomiting cough
Portable polio
Scarves
Tetanus
1.2. Sexually transmitted diseases:
Chlamydia infections
Gonococcal infections
Diseases caused by human immunodeficiency virus (HIV / AIDS)
Reception (Syphilis)
1.3. Viral hepatitis:
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis E
1.4. Diseases carried by food and water and diseases dependent on the environment:
Botulism
Campylobacteriosis
Cryptosporidiosis
Lambliasis (giardiasis)
Infections caused by E. coli enterohaemorrhagica
Leptospirosis
Listeriosis
Salmonella
Shigelosis
Spleen
Toxoplasmosis
Trichinosis
Yersiniosis
Rotavirus infections
1.5. Other diseases:
1.5.1. Diseases transmitted by non-conventional agents
Variant of transmissible spongiform encephalopathies (Creutzfeldt-Jakob disease)
1.5.2. Air-borne diseases
Legionella
Meningococcal diseases
Pneumococcal infections
Tubericide
Severe acute respiratory syndrome (SARS)
1.5.3. Zoonoses (other than those mentioned in 1.4.)
Brucelosis
Echinococcosis
Rabies
Bird flu transmitted to humans
West Nile fever virus infection
Q fever
Tularemia
Lyme disease
Tick encephalitis
1.5.4. Serious diseases
Cholera
Malaria
Plague
Viral haemorrhagic fever
1.5.5. Other diseases
Chicken pox
Shingles
Příloha č. 2
Annex No 2 to Decree No 473 / 2008 Coll.
Diphtheria epidemiological alertness system
Clinical definition of disease
1. Clinical image consistent with diphtheria of the airway (feverish upper respiratory tract disease, characterised by a coating on almonds, larynx or nasal mucosa in combination with sore throat and increased temperature) or diphtheria of another location (a disease characterised by skin, conjunctival, ear, genital ulcers or ulcers of another type). Incubation period 2 to 5 days.
2. Each case of diphtheria is clinically characterised by:
2.1. throat diphtheria;
2.2. laryngeal diphtheria;
2.3. nasal diphtheria;
2.4. skin diphtheria;
2.5. diphtheria of other organs.
3. The period of infection lasts from the end of the incubation period, throughout the illness, usually 14 days, rarely longer than 1 month.
Laboratory diagnostics
Laboratory diagnostics shall be performed by isolation of the trough (C. diphtheriae, or C. ulcerans) producing toxin from a clinical specimen. The investigating laboratory shall send each strain of C. diphtheriae and C. ulcerans to the National Reference Laboratory for Pertussis and Diphtheria for further identification.
Epidemiological criteria
Epidemiological link - human transmission of a disease in which one of the cases is laboratory confirmed.
Classification of a disease case
A. Possible: Clinically relevant case
B. Likely: Clinically relevant case in the epidemiological context
C. Confirmed: Clinically relevant case, which is laboratory confirmed by isolation of toxic corynebacterium strain
For the needs of national surveillance is further defined:.
No sign of a toxic strain carrier
Data collection and reporting
A care provider who diagnoses diphtheria shall report to the public health authority a confirmed and probable disease including the carrier of a toxic strain and the death of the disease, both cases of diphtheria and diphtheria of other localities, as well as non-characteristic cases of toxic strain carriers. Cases of non-toxic strains of C. diphtheriae or C. ulcerans are not reported. Any laboratory that isolates C. diphtheriae or C. ulcerans shall report to the public health authority the isolation of these agents under another legislation (2).
Epidemiological investigation if diphtheria is suspected
The person providing care 1) who has expressed suspicion of diphtheria will swab the site of clinical manifestations, such as tonsilus, nose, skin, on a culture examination and arrange for its transport to the testing laboratory without delay. The investigating laboratory shall send each isolated strain of C. diphtheriae and C. ulcerans for verification and quantitative determination of toxin production to the National Reference Laboratory for Diphtheria and Pertussis. Epidemiological investigations, including vaccination control, shall be carried out by the public health authority in particular in order to identify the source of infection and the route of transmission.
Anti-epidemic measures in diphtheria outbreak
1. The disease reports shall be subject to cases of respiratory diphtheria and diphtheria of other locations, as well as to non-characteristic cases of toxic strain carriers, in accordance with Article 5.
2. Ensure the collection of biological material to verify the diagnosis, its transport to the relevant investigating laboratory.
3. The procedure for isolation is governed by other legislation2).
4. A child who has experienced a disease can be admitted to a nursery school, school, school establishment for the performance of constitutional education and protective education, special childcare facilities, social services facilities and similar facilities (hereinafter referred to as "collective facilities'), if the results of the clinical examination are positive and the two last cultivation tests from the nose and neck were negative with regard to C. diphtheriae and C. ulcerans (otherwise with the consent of the public health authority, hereinafter referred to as" OOVZ ').
5. Medical supervision shall be carried out for 7 days in natural persons who have been in contact with a patient or carrier of a toxic strain. At the beginning and end of the reference period, a swab shall be taken from the nose and neck for microbiological examination.
6. During medical supervision, only non-susceptible children are admitted to the establishment by diphtheria, susceptible children up to 7 days, provided that none of the children is a carrier of the toxic strain C. diphtheriae.
7. Non-susceptible children with diphtheria from families where diphtheria has occurred may reach the establishment, susceptible children with diphtheria up to 7 days after last contact with the patient.
Příloha č. 3
Annex No. 3 to Decree No. 473 / 2008 Coll.
Vomiting cough epidemiological alertness system
Clinical definition of disease
1. A clinical picture consistent with pertussis, i. e. a cough lasting at least 2 weeks with one of the following symptoms: cough seizures, stinging cough or vomiting after a cough attack with no other apparent causes or apnoic pause in infants. Incubation period 7 to 21 days.
2. Typical form of pertussis:
The disease usually lasts 6 to 8 weeks and has 3 stages: catoral (1 to 2 weeks), paroxysmal (2 to 6 weeks) and convalescent (1 to 3 weeks). Initial manifestations (runny nose, tear, mild dry irritant cough, subfebrils) correspond to the symptoms of a common cold. During the cataral stage, the dry irritant cough gets worse and passes into a binge cough - paroxysmal stage. The number and severity of seizures increases during this period. The seizure is characterized by a series of short exspires ended by a characteristic elastic elastic inspiration. Cough seizures are accompanied by vomiting and vomiting and appear both during the day and at night. The convalescent stage is characterised by a reduction in seizures and a reduction in cough. The most serious course of disease is in children under 1 year of age.
3. In children under 15 years of age and adults, pertussis is usually found in lighter form. It runs as a dry irritant cough lasting 2 weeks or more. It can be accompanied by both vomiting and vomiting, but without typical seizures.
4. The period of infection begins at the end of the incubation period, which lasts 7 - 21 days. The highest is in the early period of the bluetongue stage, then gradually decreasing. It usually ends three weeks after the start of paroxysmal stage or five days after antibiotic therapy.
5. Parapertus unlike pertussis has a lower manifestation. The typical course of parapertus is reminiscent of a pertussis with a short cataral stage and a shorter paroxysmal stage.
Laboratory diagnostics
1. The evidence of a specific anti-cough antibody response in persons not recently vaccinated (during the previous 8 weeks).
2. Detection of Bordetella pertussis nucleic acid.
3. Isolation of Bordetella pertussis (or B. parapertussis) from a clinical specimen.
4. The standard laboratory test for the diagnosis of gingival cough is the Bordetella pertussis or B. parapertusis culture certificate.
5. For serological examination 2 blood samples at 3 weeks interval are taken. The first sample shall be taken as soon as possible at the acute stage. A precondition for serological diagnosis is the simultaneous examination of the first and second serum samples. A significant (at least 4-fold) increase in antibody levels (against pertussis or parapertussis) or seroconversion from negativity to positivity is confirmed by an ongoing disease.
6. Any level of antibodies in a single sample is not evidence of an acute disease.
7. The investigating laboratory shall send each isolated strain B. pertussis and B. parapertussis for verification to the National Reference Laboratory for Pertussis and Diphtheria.
Epidemiological criteria
Epidemiological link - human transmission of a disease in which one of the cases is laboratory confirmed.
Classification of a disease case
A. Possible: A case that meets the definition of a clinical case.
B. Likely: A case that meets the definition of a clinical case and has an epidemiological link.
C. Confirmed: Case that meets the definition of a clinical case and is laboratory confirmed.
Data collection and reporting
A care provider who diagnoses a disease with gushing cough reports to the public health authority the disease with gushing cough and death of the disease.
Epidemiological investigation when the presence of a gag is suspected
The person providing care (1) who has expressed suspicion of gushing cough disease shall provide for clinical sampling for culture or PCR testing and blood collection for serological examination and transport of biological material to the testing laboratory without delay; carry out further blood sampling in at least 3 weeks. The person providing care (1) and the investigating laboratory shall report to the public health authority the results referred to in Article 4. The investigating laboratory shall send each isolated strain B. pertussis and B. parapertussis for verification to the National Reference Laboratory for Pertussis and Diphtheria. Epidemiological investigations, including vaccination control, shall be carried out by the public health authority in particular in order to identify the source of infection and the route of transmission.
Anti-epidemic measures in the outbreak of disease with gushing cough
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Decree No. 473 / 2008 Coll., on an epidemiological vigilance system for selected infections |
|---|---|
| Regulation Type | Order |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 30.12.2008 |
|---|---|
| Effective from | 01.01.2009 |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0